ArticleBMC veterinary research2025

PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer.

Jayson Cagadas Pasaol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.